Significant decrease in injection risk behaviours among participants in a needle exchange programme

References

• Degenhardt L, Peacock A, Colledge S, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Global Health. 2017;5:e1192–e207.
   PubMed Web of Science ®Google Scholar
• Grebely J, Larney S, Peacock A, et al. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction (Abingdon, England). 2018;114:150–166.
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen. [The National Board of Health and Welfare]. En uppskattning av omfattningen av injektionsmissbruket i Sverige [An estimate of the extent of the injection drug abuse in Sweden]. Stockholm, Sweden: Socialstyrelsen; 2013. p. 16.
   Google Scholar
• Kaberg M, Hammarberg A, Lidman C, et al. Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program. Infectious Diseases (London, England). 2017;49:728–736.
   PubMed Web of Science ®Google Scholar
• Kaberg M, Naver G, Hammarberg A, et al. Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV elimination. J Viral Hepat. 2018;25:1452–1461.
   PubMed Web of Science ®Google Scholar
• Fraser H, Martin NK, Brummer-Korvenkontio H, et al. Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. J Hepatol. 2017;68:402–411.
   Web of Science ®Google Scholar
• Karlsson N, Santacatterina M, Kall K, et al. Risk behaviour determinants among people who inject drugs in Stockholm, Sweden over a 10-year period, from 2002 to 2012. Harm Reduct J. 2017;14:57.
   PubMed Web of Science ®Google Scholar
• WHO. Combating hepatitis B and C to reach elimination to 2030. 2016.
   Google Scholar
• MacArthur GJ, van Velzen E, Palmateer N, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25:34–52.
   PubMed Web of Science ®Google Scholar
• Palmateer NE, Taylor A, Goldberg DJ, et al. Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PloS One. 2014;9:e104515.
   PubMed Web of Science ®Google Scholar
• Platt L, Minozzi S, Reed J, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9:CD012021.
   PubMed Web of Science ®Google Scholar
• Larney S, Peacock A, Leung J, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Global Health. 2017;5:e1208–e1220.
   PubMed Web of Science ®Google Scholar
• Fernandes RM, Cary M, Duarte G, et al. Effectiveness of needle and syringe Programmes in people who inject drugs - an overview of systematic reviews. BMC Public Health. 2017;17:309.
   PubMed Web of Science ®Google Scholar
• Palmateer N, Kimber J, Hickman M, et al. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction (Abingdon, England). 2010;105:844–859.
   PubMed Web of Science ®Google Scholar
• Grebely J, Bruneau J, Lazarus JV, et al. Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs. Int J Drug Policy. 2017;47:51–60.
   PubMed Web of Science ®Google Scholar
• Aspinall EJ, Nambiar D, Goldberg DJ, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:235–248.
   PubMed Web of Science ®Google Scholar
• Hagan H, Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health. 2000;77:369–382.
   PubMed Web of Science ®Google Scholar
• Monterroso ER, Hamburger ME, Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). J Acquired Immune Deficiency Syndromes (1999). 2000;25:63–70.
   PubMed Web of Science ®Google Scholar
• Bluthenthal RN, Kral AH, Gee L, et al. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS (London, England). 2000;14:605–611.
   PubMed Web of Science ®Google Scholar
• Cox GM, Lawless MC, Cassin SP, et al. Syringe exchanges: a public health response to problem drug use. Ir Med J. 2000;93:143–146.
   PubMedGoogle Scholar
• Gibson DR, Brand R, Anderson K, et al. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquired Immune Deficiency Syndromes (1999). 2002;31:237–242.
   PubMed Web of Science ®Google Scholar
• Hart GJ, Carvell AL, Woodward N, et al. Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year. AIDS (London, England). 1989;3:261–265.
   PubMed Web of Science ®Google Scholar
• Huo D, Bailey SL, Garfein RS, et al. Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illinois, 1994–1996. Subst Use Misuse. 2005;40:63–76.
   PubMed Web of Science ®Google Scholar
• Ouellet L, Huo D, Bailey SL. HIV risk practices among needle exchange users and nonusers in Chicago. J Acquired Immune Deficiency Syndromes (1999). 2004;37:1187–1196.
   PubMed Web of Science ®Google Scholar
• Schoenbaum EE, Hartel DM, Gourevitch MN. Needle exchange use among a cohort of injecting drug users. AIDS (London, England). 1996;10:1729–1734.
   PubMed Web of Science ®Google Scholar
• van Ameijden EJ, Coutinho RA. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS (London, England). 1998;12:625–633.
   PubMed Web of Science ®Google Scholar
• van den Hoek JA, van Haastrecht HJ, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health. 1989;79:1355–1357.
   PubMed Web of Science ®Google Scholar
• Vertefeuille JM, Tun W, Huettner S, et al. Decline in self-reported high-risk injection-related behaviors among HIV-seropositive participants in the Baltimore needle exchange program. AIDS Behav. 2000;4:381–388.
   Google Scholar
• Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquired Immune Deficiency Syndromes Human Retrovirol. 1997;16:400–406.
   PubMedGoogle Scholar
• Wood E, Tyndall MW, Spittal PM, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS (London, England). 2002;16:941–943.
   PubMed Web of Science ®Google Scholar
• Ökad tillgänglighet till sprututbytesverksamheter i Sverige [Increased Access to Needle Exchange Programs in Sweden] (Prop. 2016/17:15). Stockholm (Sweden): Parliament Documents; 2016.
   Google Scholar
• Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121–130.
   PubMed Web of Science ®Google Scholar
• Montgomery SB, Hyde J, De Rosa CJ, et al. Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse. 2002;28:453–475.
   PubMed Web of Science ®Google Scholar
• Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80:137–146.
   PubMed Web of Science ®Google Scholar
• Sherman SG, Latkin CA, Gielen AC. Social factors related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse. 2001;36:2113–2136.
   PubMed Web of Science ®Google Scholar
• Huo D, Ouellet LJ. Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study. J Acquired Immune Deficiency Syndromes (1999). 2007;45:108–114.
   PubMed Web of Science ®Google Scholar
• Iversen J, Page K, Madden A, et al. HIV, HCV, and health-related harms among women who inject drugs: implications for prevention and treatment. J Acquired Immune Deficiency Syndromes (1999). 2015;69:S176–S181.
   PubMed Web of Science ®Google Scholar
• Malinowska-Sempruch K. What interventions are needed for women and girls who use drugs? A global perspective. J Acquired Immune Deficiency Syndromes (1999). 2015;69:S96–S97.
   PubMed Web of Science ®Google Scholar
• El-Bassel N, Strathdee SA. Women who use or inject drugs: an action agenda for women-specific, multilevel, and combination HIV prevention and research. J Acquired Immune Deficiency Syndromes (1999). 2015;69:S182–S190.
   PubMed Web of Science ®Google Scholar
• Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet (London, England). 2010;376:268–284.
   PubMed Web of Science ®Google Scholar
• Rhodes T, Singer M, Bourgois P, et al. The social structural production of HIV risk among injecting drug users. Social Sci Med (1982). 2005;61:1026–1044.
   PubMed Web of Science ®Google Scholar
• Booth RE, Kwiatkowski CF, Mikulich-Gilbertson SK, et al. Predictors of risky needle use following interventions with injection drug users in Ukraine. Drug Alcohol Depend. 2006;82:S49–S55.
   PubMed Web of Science ®Google Scholar
• Palmateer NE, Hutchinson SJ, Innes H, et al. Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe. Int J Drug Policy. 2013;24:85–100.
   PubMed Web of Science ®Google Scholar
• Martin NK, Hickman M, Hutchinson SJ, et al. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis. 2013;57:S39–S45.
   PubMed Web of Science ®Google Scholar
• Turner KM, Hutchinson S, Vickerman P, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction (Abingdon, England). 2011;106:1978–1988.
   PubMed Web of Science ®Google Scholar
• Vorobjov S, Des Jarlais DC, Abel-Ollo K, et al. Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys. Int J Drug Policy. 2013;24:150–155.
   PubMed Web of Science ®Google Scholar
• Folch C, Casabona J, Espelt A, et al. High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants–is prevention failing? Subst Use Misuse. 2016;51:250–260.
   PubMed Web of Science ®Google Scholar
• Palmateer N, Hutchinson S, McAllister G, et al. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J Viral Hepat. 2014;21:25–32.
   PubMed Web of Science ®Google Scholar
• WHO. Global Health Sector strategy on viral hepatitis 2016–2021, towards ending viral hepatitis. Geneva; 2016.
   Google Scholar
• Kerr T, Small W, Buchner C, et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010;100:1449–1453.
   PubMed Web of Science ®Google Scholar
• Bluthenthal RN, Ridgeway G, Schell T, et al. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction (Abingdon, England). 2007;102:638–646.
   PubMed Web of Science ®Google Scholar
• Bluthenthal RN, Anderson R, Flynn NM, et al. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend. 2007;89:214–222.
   PubMed Web of Science ®Google Scholar
• Sherman SG, Patel SA, Ramachandran DV, et al. Consequences of a restrictive syringe exchange policy on utilisation patterns of a syringe exchange program in Baltimore, Maryland: implications for HIV risk. Drug Alcohol Rev. 2015;34:637–644.
   PubMed Web of Science ®Google Scholar